The ESC Textbook of Heart Failure

• Section 1: Universal definition of heart failure 1.1: Andrew JS Coats, Biykem Bozkurt and Petar M. Seferovic: Universal definition of heart failure Section 2: Epidemiology of heart failure 2.1: Amy Groenewegen, Ivan Milinkovi?, Arno W Hoes, Arend Mosterd, Frans H Rutten: Epidemiology of heart failure Section 3: Etiology of heart failure 3.1: (Rocco Antonio Montone, Maurizio Volterrani, Jian Zhang and Filippo Crea: Coronary artery disease 3.2: Athanasios Manolis and Yuri Lopatin: Hypertension 3.3: Ana Pardo Sanz, Ivan Milinkovic and Josep Zamorano: Valvular heart disease 3.4.1: Thomas Thum, Stephane Heymans, and Johannes Backs: Genetic basis of cardiomyopathies 3.4.2: Petar M.Seferovic, Biykem Bozkurt, and Marija Polovina: Dilated and hypokinetic non-dilated cardiomyopathy 3.4.3: Perry Elliott, Michel Noutsias and Aris Anastasakis: Hypertrophic cardiomyopathy 3.4.4: Claudio Rapezzi, Alberto Aimo, Ales Linhart, and Andre Keren: Restrictive cardiomyopathy 3.4.5: Cristina Basso, Hugh Calkins and Domenico Corrado: Arrhythmogenic right ventricular cardiomyopathy 3.4.6: Karen Sliwa and Johann Bauersachs: Peripartum cardiomyopathy 3.4.7: Jelena Templin-Ghadri, Michael Würdinger, Johann Bauersachs, and Christian Templin: Takotsubo cardiomyopathy 3.5: Stephane Heymans, Arsen Risti?, Yehuda Adler, and Massimo Imazio: Myocarditis and pericarditis 3.6: Werner Budts and Jolien Roos-Hesselink: Congenital heart disease 3.7: Martin Huelsmann, Jelena Seferovic and Francesco Cosentino: Endocrine and metabolic disorders 3.8: Lina Badimon, Stefan Anker and Stephan von Haehling: Obesity 3.9: Alexander Lyon, Dimitrios Farmakis, Daniela Cardinale and Teresa Lopez Fernandez: Cancer and cancer therapy 3.10: Antonello Gavazzi, Maria Nunes, and Fausto Pinto: Toxins (e.g. alcohol etc.) and infections Section 4: Prevention of heart failure 4.1: Massimo Piepoli, Maria Benedetta Matrone, Paul Dendale, and Shelley Zieroth: Prevention of heart failure Section 5: Pathophysiology of heart failure 5.1: (Junjie Xiao, Thomas Thum, Gianluigi Condorelli and Johannes Backs: Molecular and cellular mechanisms 5.2: Edoardo Bertero and Chistoph Maack: Alterations in myocardial metabolism 5.3: Javier Diez Martinez and Hans-Peter Brunner La Rocca: Ventricular remodelling 5.4: Antoni Bayes Gennis and Faiez Zannad: Neurohormonal activation 5.5: Urlich Hofmann, Stefan Frantz and Nikolaos Frangogiannis: Immune-mediated mechanisms 5.6: Stephane Heymans: Inflammation, oxidative stress and endothelial dysfunction 5.7: Alterations in peripheral circulation and renal function (: Alterations in peripheral circulation and renal function 5.8: (Stephan von Haehling and Wolfram Doehner: Systemic adaptations in metabolism and nutritive status Section 6: Clinical phenotypes of chronic heart failure 6.1: Thomas Luscher, Petar Seferovic, and Brian Halliday: HFrEF 6.2: Adrian Voors, Brenda Moura, Lars Lund and Carolyn Lam: HFmrEF 6.3: Rudolf De Boer, Burkert Pieske, and Barry Borlaug: HFpEF 6.4: Thomas Luscher, Thomas M. Gorter, Susanna Price, Michael Gatzoulis and Anneline Te Riele: Right heart failure Section 7: Chronic heart failure: diagnostic and prognostic assessment 7.1: Michel Komajda, Piotr Ponikowski, and Evgeny Shlyakhto: Clinical assessment 7.2: Rudolf de Boer, Antioni Bayes Genis and James Januzzi: Biomarkers in diagnostic and prognostic assessment 7.3: Philippe Debonnaire, Victoria Delgado, Thor Edvardsen, Bogdan Popescu, and Jeroen Bax: Echocardiography 7.4: Danilo Neglia and Alessia Gimelli: Nuclear medicine 7.5: Stephan Achenbach and Amina Rakisheva: Cardiac computed tomography 7.6: Anna Baritussio, Noor Sharrack, Sven Plein, and Chiara Bucciarelli-Bucci: Cardiac magnetic resonance 7.7: Luca Moderato, Davide Lazzeroni, Stamatis Adamopoulos, Alain Cohen-Solal and Massimo Piepoli: Cardiopulmonary exercise 7.8: Christian Hamm, Brigit Assmus and Veselin Mitrovic: Cardiac catheterization, invasive imaging and haemodynamic assessment Section 8: Chronic heart failure: pharmacological management 8.1: Roberto Ferrari, Gabriele Guardigli, and Biykem Bozkurt: Angiotensin converting enzyme inhibitors 8.2: Ileana L. Pina and Magdy Abdelhamid: Angiotensin I receptor blockers 8.3: Petar M. Seferovic, Michele Senni, Marija Polovina and Andrew JS Coats: ARNI 8.4: Daniela Tomasoni, Marianna Adamo, Hiroyuki Tsutsui, and Marco Metra: Beta-blockers 8.5: Bertram Pitt, João Pedro Ferreira and Faiez Zannad: Mineralocorticoid receptor agonists 8.6: Michael Bohm and Michel Komajda: Ivabradine 8.7: Eftihia Polyzogopoulou, Maria Nikolaou, John Parissis and Alexandre Mebazaa: Vasodilators 8.8: Udo Bavendiek and Johann Bauersachs: Digitalis glycosides 8.9: Jeroen Dauw, Stephen Gottlieb and Wifried Mullens: Diuretics 8.10: Jan Biegus, Piotr Ponikowski, and Christoph Maack: Inotropes and inodilators 8.11: Petar M. Seferovic, Francesco Cosentino, Giuseppe Rosano and James Januzzi: SGLT2 inhibitors 8.12: Stefan Agewall, Isabelle van Gelder, and Irene Savelieva: Ancillary pharmacological treatment options 8.13: Giuseppe Rosano, Gerasimos Filippatos, and Randall Starling: New and emerging therapies Section 9: Chronic heart failure: non-pharmacological management 9.1: Gianluigi Savarese, Cecilia Linde and Kenneth Dickstein: Implantable cardioverter defibrillator 9.2: Pieter Martens, Eva Goncalvesova, and Wilfried Mullens: Cardiac resynchronization therapy 9.3: Felix Schoenrat, Franz-Josef Neumann, Miguel Sousa Uva and Volkmar Falk: Cardiac surgery 9.4: Stefan Orwat, Stefan Anker and Helmut Baumgartner: Valve interventions 9.5: Andrew JS Coats, Piotr P Ponikowski, Maria-Rosa Costanzo and William T. Abraham: Ancillary procedures 9.6: Maurizio Volterrani, Alain Cohen-Solal, Stamatis Adamopulos, Dimitris Miliopoulos, Ferdinando Iellamo, and Massimo Piepoli: Cardiac rehabilitation Section 10: Acute heart failure 10.1: Ovidiu Chioncel, Gerasimos Filippatos, Alexandre Mebazaa, Veli-Pekka Harjola, and Josep Masip: Acute heart failure: diagnostic and prognostic assessment 10.2: Katerina Fountoulaki, John Parissis, Sean Collins, Mehmet Birhan Yilmaz, and Alexandre Mebazaa: Acute heart failure: management Section 11: Advanced heart failure 11.1: Tuvia Ben Gal, Mariell Jessup, and Maria-Rosa Costanzo: Advanced heart failure: assessment 11.2: Daniela Tomasoni, Marianna Adamo, and Marco Metra: Advanced heart failure: management 11.3: Mandeep Mehra and Finn Gustafsson: Mechanical circulatory support 11.4: Davor Milicic, Mandeep Mehra, and Randall Starling: Heart transplantation 11.5: Tiny Jaarsma, Donna Fitzsimons, Lisa Hjelmfors, Loreena Hill, Ekaterini Lambrinou, and Anna Strömberg: Palliative care and end-of-life management Section 12: Comorbidities and clinical conditions 12.1: Pieter Martens and Hans-Peter Brunner-La Rocca: Chronic kidney disease: Clinical Aspects of Chronic Kidney Disease in Heart Failure 12.2: Javed Butler, Wilfried Mullens and Kevin Damman and João Pedro Ferreira: Dyskalaemia 12.3: Josep Masip, Karina Portillo and Mattia Arrigo: Chronic lung disease 12.4: Piergiuseppe Agostoni, Elisabetta Salvioni, Maria Rosa Costanzo, and Andrew JS Coats: Ventilatory Abnormalities and Sleep Disordered Breathing 12.5: Irene M. Lang and Stephan Rosenkranz: Pulmonary hypertension 12.6: Silvia Priori, Alessandro Trancuccio, Alessia Chiara Latini, Carlo Arnò, Deni Kukavica, and Andrea Mazzanti: Cardiac rhythm disorders 12.7: Paulus Kirchhof, Andreas Metzner, Ruben Schleberger and Douglas Packer: Management of atrial fibrillation in heart failure 12.8: Giuseppe Rosano, Javed Butler, Petar M. Seferovi?, Jelena Seferovic and Francesco Cosentino: Diabetes, metabolic syndrome and endocrine disorders 12.9: Giacomo De Luca, Luca Moroni, Alessandro Tomelleri, R Marcolongo, Lorenzo Dagna, Alida LP Caforio, and Marco Matucci-Cerinic: Systemic immune medicated diseases 12.10: Yuri Lopatin and Gianluigi Savarese: Liver and gut dysfunction 12.11: Ewa Jankowska, Piotr Ponikowski, and Stefan Anker: Anaemia and iron deficiency 12.12: Wolfram Doehner, Cristiana Vitale, and Mehmet Birhan Yilmaz: Depression and cognitive impairment 12.13: Alexander Lyon, Dimitrios Farmakis, Rudolf de Boer, and Yuri Belenkov: Cancer 12.14: Johann Bauersachs, Denise Hilfiker-Kleiner and Karen Sliwa: Pregnancy 12.15: Ewa Jankowska, Cristiana Vitale and Dong-Ju Choi: Frailty Section 13: Self-care and patient education 13.1: Tiny Jaarsma, Loreena Hill, Ekaterini Lambrinou, Anna Stromberg, and Tina Hansen: Self-care and patient education Section 14: Multidisciplinary approach to heart failure management 14.1: Loreena Hill, Friedrich Koehler, Tiny Jaarsma, Marija Polovina, Katherine McCreary, and Andrew JS Coats: Multidisciplinary approach to heart failure management Section 15: Clinical trial design and interpretation 15.1: Gianluigi Savarese, Marija Polovina and Gerasimos Filippatos: Clinical trial design and interpretation Section 16: Digital health in heart failure 16.1: Arvind Singhal and Martin Cowie: Digital health in heart failure Section 17: Big data in heart failure 17.1: Mamas Mamas and Dipak Kotecha: Big data in heart failure Section 18: Telemedicine and remote monitoring 18.1: Tarek Bekfani, Friedrich Koehler and William T. Abraham: Telemedicine and remote monitoring

The textbook is of utmost quality and provides a massive tool to physicians at all levels. The quantity of information provided is exceptional, and the coverage of topics relating to heart failure is as precise as ever [...] The book outranks many of its related counterparts as it not only covers the theoretical aspects of the disease but also dives deep into the management strategies, diagnostic technologies, and latest advances in the disease.